ABCL
Price
$6.52
Change
-$0.28 (-4.12%)
Updated
Jul 13 closing price
Capitalization
1.99B
22 days until earnings call
Intraday BUY SELL Signals
VERU
Price
$2.56
Change
-$0.22 (-7.91%)
Updated
Jul 13 closing price
Capitalization
41.01M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs VERU

ABCL vs VERU Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. VERU commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and VERU is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ABCL: $6.52 vs. VERU: $2.56)
Brand notoriety: ABCL and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 33% vs. VERU: 6%
Market capitalization -- ABCL: $1.99B vs. VERU: $41.01M
ABCL [@Biotechnology] is valued at $1.99B. VERU’s [@Biotechnology] market capitalization is $41.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while VERU’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 5 bearish.
  • VERU’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VERU is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -17.15% price change this week, while VERU (@Biotechnology) price change was -9.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 05, 2026.

VERU is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.99B) has a higher market cap than VERU($41M). ABCL YTD gains are higher at: 90.643 vs. VERU (19.626). VERU has higher annual earnings (EBITDA): -28.02M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. VERU (30.8M). VERU has less debt than ABCL: VERU (2.83M) vs ABCL (140M). ABCL has higher revenues than VERU: ABCL (79.2M) vs VERU (0).
ABCLVERUABCL / VERU
Capitalization1.99B41M4,854%
EBITDA-167.02M-28.02M596%
Gain YTD90.64319.626462%
P/E RatioN/A0.41-
Revenue79.2M0-
Total Cash505M30.8M1,640%
Total Debt140M2.83M4,942%
FUNDAMENTALS RATINGS
VERU: Fundamental Ratings
VERU
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLVERU
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
VERU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IMVP20.12N/A
+0.02%
Invesco India ETF
ULVM106.97N/A
N/A
VictoryShares US Value Momentum ETF
AZTD33.17N/A
N/A
Aztlan Global Stock Sel Dm SMID ETF
DRSK28.55-0.21
-0.73%
Aptus Defined Risk ETF
WAR30.46-1.37
-4.30%
U.S. Global Technology and Aerospace and Defense ETF

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with INDP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-7.91%
INDP - VERU
45%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
-3.21%
ABCL - VERU
34%
Loosely correlated
-4.12%
REVB - VERU
33%
Poorly correlated
-0.81%
COGT - VERU
32%
Poorly correlated
-3.63%
More